Table 6.
Comparison of HIV-associated lab results for phases I and II
| Phase I, N = 11 | Phase II, N = 6 | Reference values | ||||
|---|---|---|---|---|---|---|
| Baseline mean ± SE | 3 Weeks mean ± SE | Baseline mean ± SE | 3 Weeks mean ± SE | 3 Months mean ± SE | ||
| Percent CD4+ of all lymphocytes | 23 ± 2 | 23 ± 2 | 25 ± 2 | 23 ± 3 | 25 ± 3 | 31–59% |
| CD4+ cells μL-1 | 447 ± 47 | 475 ± 65 | 426 ± 48 | 417 ± 50 | 484 ± 67 | 359–1,519 |
| HIV-1 RNA by PCR copies/mL | 61,884 ± 24,767 | 50,208 ± 25,231 | 28,990 ± 17,428 | 58,566 ± 46,924 | 18,015 ± 7,130 | 2.56–3.18 |
| Log10 HIV-1 RNA | 4.34 ± 0.23 | 4.26 ± 0.21 | 4.02 ± 0.30 | 4.10 ± 0.36 | 3.89 ± 0.32 | |
Mean ± SE mean ± standard error